Project Grant R01AI175440
Award Date
9/1/24
Completion Date
8/31/29
Dollars Obligated
$729K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Little Rock, AR 72205, USA
Similar Awards
The National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded a $569,210 Project Grant to the University of Colorado Boulder. The five-year grant, effective February 1, 2025, supports research to structurally and functionally characterize three proteins responsible for antimicrobial resistance, screen for probes to define inhibitory strategies, and develop a platform to quantitatively test the impact of target...
This federal Project Grant award of $794,849 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research by Cedars-Sinai Medical Center to investigate mechanisms of cefiderocol resistance and cross-protection in Pseudomonas aeruginosa (PA). The key goals are to: 1) determine how CPX sensor mutations in PA affect efflux pump expression and siderophore production, leading to cefiderocol...
This federal Project Grant award of $637,275 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to uncover the mechanisms by which bacterial pathogens rapidly develop tolerance to chemical stressors, such as antibiotics. The research aims to define novel stress tolerance mechanisms in pathogens, with implications for improving antibacterial therapies and public health. Key focus areas...
This federal Project Grant award, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), funds research focused on developing novel antibiotics to address the growing threat of multi-drug resistant bacterial pathogens. The $749,417 award to President and Fellows of Harvard College supports the synthesis and biological evaluation of new antibiotic compounds that target the lipoprotein transport...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to understand the mechanism of intrinsic antibiotic resistance in Enterococcus faecalis bacteria. The $103,256 award, effective December 1, 2025 through June 30, 2030, will enable the Medical College of Wisconsin, Inc. to investigate the role of the penicillin binding protein 4 (PBP4) pedestal domain in...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $175,000 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to California State University, Fresno. The grant, titled "Surveillance of Drug-Resistant Bacteria in Resource-Limited Settings: A Focus on Cost-Effective Long-Read Sequencing of Eyedrop-Associated P. Aeruginosa and Locally Sourced Metagenomic Samples," aims to develop a decentralized antimicrobial resistance...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a 5-year, $395,496 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to The Regents of the University of California, San Francisco (UCSF) effective August 23, 2024. The funding will support a research project titled "Metagenomic Surveillance of Pathogen and Antimicrobial Resistance Gene Transmission in Hospitalized Neonates." The project aims to leverage metagenomic next-generation sequencing...
This federal Project Grant award of $254,478 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research) supports research at The University of Texas Southwestern Medical Center to identify mechanisms of resistance to pathogen-specific antibacterial antisense compounds called peptide-phosphorodiamidate morpholino oligomers (PPMOs) and develop strategies to overcome them. The research aims to study resistance in key gram-negative bacterial...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $474,363.00 to Rowan University to develop novel, daptomycin-inspired antimicrobial peptides using non-canonical amino acids. The research aims to improve the fundamental understanding of sequence-structure-activity relationships, and implement this knowledge to create new antimicrobial compounds that mimic...
This $453,900 Project Grant was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant is funding research to develop a genome editing platform using broadly functioning phage recombinases, which can be used to genetically manipulate a wide range of bacterial species, including clinically relevant pathogens. The goal is to enable direct investigation of the genetic elements driving bacterial...